Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Regulus Therapeutics

Regulus Therapeutics reported $-6795000 in Net Income for its fiscal quarter ending in December of 2022.

Net Income Change
Alnylam Pharmaceuticals ALNY:US USD -174101000 33.39M
AstraZeneca AZN:LN USD 1.8B 902M
Biogen BIIB:US USD 387.9M 162.5M
Celldex Therapeutics CLDX:US USD -29361000 2.87M
Gilead Sciences GILD:US USD 1.01B 630M
GlaxoSmithKline GSK:LN GBP 1.49B 5M
Immunic Inc. VTL:US USD -25272000 31.2M
Incyte Corp INCY:US USD 21.7M 6.76M
Intercept Pharmaceuticals ICPT:US USD -32135000 11.31M
Ionis Pharmaceuticals IONS:US USD -124323000 71.89M
Lexicon Pharmaceuticals LXRX:US USD -31934000 1.44M
Merck & Co MRK:US USD 2.82B 196M
Sangamo BioSciences SGMO:US USD 21.13M 73.11M
Spectrum Pharmaceuticals SPPI:US USD -5007000 3.98M
Takeda 4502:JP JPY 31.13B 87.99B